ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma.
Wendi YangKehong ChenQian YuRongxin LiaoHengqiu HeYuan PengZhen Zhou YangXiaoyue ZhangPublished in: Cancer medicine (2023)
The findings of our study suggested that ADAR1 may be useful in predicting prognosis and LNM in LUAD, and may serve as a promising immune-related molecular target for LUAD patients.